Trump Thought He’d Escaped the Abortion Trap

Now the Supreme Court is facing a blockbuster case that threatens to spin out of control.

Nina Martin,  Mother Jones
May 12, 2026

By all accounts, President Donald Trump really, really did not want abortion to become a major issue this election year. But here we are, six months before the midterms, and abortion pills are back at the Supreme Court, as the state of Louisiana and abortion drug manufacturers ask to fast-track oral arguments in what is shaping up to be a blockbuster case. Conservatives are invoking the Comstock Act. And Trump’s Food and Drug Administration has been AWOL, while its top official has been forced to resign.

The swift escalation of the showdown between Louisiana and the FDA over telemedicine abortion highlights just how little control Trump has over the abortion issue—both in terms of the timeline and the outcome. Meanwhile, the case is sparking confusion, uncertainty, and dread among patients, providers, and advocates across the US.

Continued: https://www.motherjones.com/politics/2026/05/mifepristone-scotus-trump-thought-hed-escaped-the-abortion-trap/


USA – A Right-Wing Court Just Moved to Choke Off Abortion by Mail

A sweeping decision threatens to unravel one of the most important pathways to care post-Dobbs.

Nina Martin,  Mother Jones
May 1, 2026

A federal appeals court packed with conservatives has handed abortion opponents a major victory against the US Food and Drug Administration, reinstating an in-person dispensing requirement for the abortion medication mifepristone and shutting down telemedicine providers—at least temporarily—from prescribing the abortion pill across the US.

In a 3-0 order issued Friday afternoon, the Fifth US Circuit Court of Appeals granted Louisiana’s request for an injunction against FDA rule changes from 2023 that have allowed blue-state telehealth providers to send mifepristone to thousands of patients every month in states where abortion is banned. Abortion pills now account for almost two-thirds of abortions nationwide.

https://www.motherjones.com/politics/2026/05/a-right-wing-court-just-moved-to-choke-off-abortion-by-mail/


New Book Outlines Medication Abortion’s Origins—From ‘Chance’ Discovery to Decades of Clinical Tests and Global Approval

“Just Pills” author Rebecca Kelliher also discusses how the U.S. stacks up against Latin America on abortion rights, and what we can learn from the region’s fight for reproductive justice.

Dec 16, 2025
Catesby Holmes

The abortion drug mifepristone has transformed abortion care in the U.S. since its approval by the Food and Drug Administration 25 years ago.

…Journalist Rebecca Kelliher’s recent book, Just Pills, traces the history of abortion medications, starting with misoprostol’s whispered origins among Brazilian women in the 1980s as a “pill that makes your period back” through decades of clinical trials and widespread use in almost 100 countries.

Rewire News Group spoke with Kelliher about abortion politics, the disinformation that swirls around reproductive rights, and inspiration from abroad.

Continued: https://rewirenewsgroup.com/2025/12/16/mifepristone-just-pills-rebecca-kelliher-book/


This abortion method doesn’t involve doctors — and many of them consider it safe

June 22, 2025
By Abby Wendle, Liana Simstrom
Podcast: 43-Minute Listen, with transcript

This story is an accompaniment to a three-part podcast series released by NPR's Embedded and Futuro Media.

For nearly four years, Dr. Maya Bass's commute included a monthly plane ride from Philadelphia to Oklahoma to provide abortions at a clinic there. Starting in 2018, she took these trips even though flying made her nauseous and she had to use vacation time from her regular job. Bass was motivated to fill a gap: Oklahoma — like all parts of the U.S. outside of a fraction of metropolitan areas — has long had a shortage of abortion providers.

Continued: https://www.npr.org/2025/06/22/g-s1-73119/abortion-mifepristone-roe-v-wade


USA – Abortion providers challenge FDA’s remaining mifepristone restrictions in federal court

“It’s really important that we protect … safe access to medication abortion no matter where people live — Virginia is playing a key role in the South right now,” Whole Woman’s Health Alliance founder and president Amy Hagstrom Miller said Monday.

By: Sofia Resnick and Charlotte Rene Woods
May 19, 2025

CHARLOTTESVILLE, Va. — Abortion pills — and questions over their inherent safety — were back in federal court Monday. Unlike a lawsuit rejected by the U.S. Supreme Court last year, plaintiffs this time are not anti-abortion activists arguing medication abortion should be banned, but abortion providers arguing the remaining restrictions should be lifted to match the drug’s 25-year record of safety and efficacy.

The suit seeks to make abortion pills more accessible by removing several existing restrictions on the U.S. Food and Drug Administration’s mifepristone-misoprostol regimen first approved in 2000. The drug was approved under the FDA’s drug safety program called Risk Evaluation and Mitigation Strategy (REMS), provisions of which have been steadily eliminated over time but not fully.

Continued: https://virginiamercury.com/2025/05/19/abortion-providers-challenge-fdas-remaining-mifepristone-restrictions-in-federal-court/


USA – Many women can’t access miscarriage drug because it’s also used for abortions

BY: CAITLIN DEWEY
OCTOBER 21, 2023

Since losing her first pregnancy four months ago, 32-year-old Lulu has struggled to return to her body’s old rhythms. Lulu, who asked to be identified by her first name to protect her privacy, bled for six full weeks after her miscarriage and hasn’t had a normal menstrual cycle since.

Such disruptions aren’t uncommon after miscarriage, which affects roughly 1 in 10 known pregnancies. But for Lulu, they’ve also served as a persistent reminder that she couldn’t access the drug mifepristone — her preferred method of care — to help her body pass the miscarriage. Instead, her doctor prescribed a drug called misoprostol, which on its own is less effective.

Continued: https://ncnewsline.com/2023/10/21/many-women-cant-access-miscarriage-drug-because-its-also-used-for-abortions/